BioNexus Gene Lab Corp. Gross Profit
BioNexus Gene Lab Corp. (BGLC) reported Gross Profit of $12.98 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:GrossProfit · last filed 2026-08-14
- BioNexus Gene Lab Corp. gross profit for the quarter ending 2026-06-30 was $12.98K, a 96.47% decline year-over-year.
- BioNexus Gene Lab Corp. gross profit for the quarter ending 2026-03-31 was -$790.00, a 100.23% decline year-over-year.
- BioNexus Gene Lab Corp. gross profit for the quarter ending 2025-12-31 was -$3.98K, a 101.29% decline year-over-year.
- BioNexus Gene Lab Corp. gross profit for the quarter ending 2025-09-30 was $377.69K, a 15.66% increase year-over-year.
- BioNexus Gene Lab Corp. gross profit for fiscal 2025 was $1.09M, a 15.84% decline from fiscal 2024.
- BioNexus Gene Lab Corp. gross profit for fiscal 2024 was $1.29M, a 3.01% decline from fiscal 2023.
- BioNexus Gene Lab Corp. gross profit for fiscal 2023 was $1.33M, a 5.60% increase from fiscal 2022.
- BioNexus Gene Lab Corp. gross profit for fiscal 2022 was $1.26M, a 44.46% decline from fiscal 2021.
| Period end | Gross Profit 3 month | Gross Profit 3 month as first filed | Gross Profit 6 month | Gross Profit 6 month as first filed | Gross Profit 9 month | Gross Profit 9 month as first filed | Gross Profit 12 month | Gross Profit 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $12.98K 10-Q · filed 2026-08-14 | $12.19K 10-Q · filed 2026-08-14 | $8.21K derived: sum of 3 quarters · filed 2026-08-14 | $385.89K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | -$790.00 10-Q · filed 2026-05-15 | -$4.77K derived: sum of 2 quarters · filed 2026-05-15 | $372.91K derived: sum of 3 quarters · filed 2026-05-15 | $740.93K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$3.98K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $373.70K derived: sum of 2 quarters · filed 2026-04-14 | $741.72K derived: sum of 3 quarters · filed 2026-08-14 | $1.09M 10-K · filed 2026-04-14 | ||||
| 2025-09-30 | $377.69K 10-Q · filed 2025-11-14 | $745.71K derived: sum of 2 quarters · filed 2026-08-14 | $1.09M 10-Q · filed 2025-11-14 | $1.40M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $368.02K 10-Q · filed 2026-08-14 | $711.51K 10-Q · filed 2026-08-14 | $1.02M derived: sum of 3 quarters · filed 2026-08-14 | $1.35M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $343.49K 10-Q · filed 2026-05-15 | $652.73K derived: sum of 2 quarters · filed 2026-05-15 | $979.26K derived: sum of 3 quarters · filed 2026-05-15 | $1.27M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $309.23K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $635.77K derived: sum of 2 quarters · filed 2026-04-14 | $924.49K derived: sum of 3 quarters · filed 2026-04-14 | $1.29M 10-K · filed 2026-04-14 | ||||
| 2024-09-30 | $326.54K 10-Q · filed 2025-11-14 | $615.26K derived: sum of 2 quarters · filed 2025-11-14 | $980.29K 10-Q · filed 2025-11-14 | $1.25M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $288.72K 10-Q · filed 2025-08-18 | $653.75K 10-Q · filed 2025-08-18 | $920.31K derived: sum of 3 quarters · filed 2025-08-18 | $1.27M derived: sum of 4 quarters · filed 2025-08-18 | ||||
| 2024-03-31 | $365.03K 10-Q · filed 2025-05-15 | $631.59K derived: sum of 2 quarters · filed 2025-05-15 | $985.92K derived: sum of 3 quarters · filed 2025-05-15 | $1.33M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $266.56K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $620.89K derived: sum of 2 quarters · filed 2025-04-15 | $960.60K derived: sum of 3 quarters · filed 2025-04-15 | $1.33M 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | $354.33K 10-Q · filed 2024-11-15 | $694.05K derived: sum of 2 quarters · filed 2024-11-15 | $1.06M 10-Q · filed 2024-11-15 | $1.40M derived: sum of 4 quarters · filed 2024-11-15 | ||||
| 2023-06-30 | $339.71K 10-Q · filed 2024-08-14 | $708.61K 10-Q · filed 2024-08-14 | $1.05M derived: sum of 3 quarters · filed 2024-08-14 | $1.35M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $368.90K 10-Q · filed 2024-05-15 | $708.12K derived: sum of 2 quarters · filed 2024-05-15 | $1.01M derived: sum of 3 quarters · filed 2024-05-15 | $1.27M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $339.23K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | $638.73K derived: sum of 2 quarters · filed 2024-04-16 | $902.70K derived: sum of 3 quarters · filed 2024-04-16 | $1.26M 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | $299.50K 10-Q/A · filed 2024-03-26 | $563.47K derived: sum of 2 quarters · filed 2024-03-26 | $919.80K 10-Q/A · filed 2024-03-26 | $1.40M derived: sum of 4 quarters · filed 2024-03-26 | ||||
| 2022-06-30 | $263.97K 10-Q · filed 2023-08-16 | $243.32K 10-Q · filed 2022-08-15 | $620.30K 10-Q · filed 2023-08-16 | $576.86K 10-Q · filed 2022-08-15 | $1.10M derived: sum of 3 quarters · filed 2023-08-16 | $1.81M derived: sum of 4 quarters · filed 2023-08-16 | ||
| 2022-03-31 | $356.33K 10-Q · filed 2023-05-09 | $333.54K 10-Q · filed 2022-05-16 | $833.50K derived: sum of 2 quarters · filed 2023-05-09 | $1.54M derived: sum of 3 quarters · filed 2023-05-09 | $2.01M derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $477.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.19M derived: sum of 2 quarters · filed 2023-03-31 | $1.65M derived: sum of 3 quarters · filed 2023-03-31 | $2.27M 10-K · filed 2023-03-31 | $2.19M 10-K · filed 2022-04-06 | |||
| 2021-09-30 | $709.19K 10-Q · filed 2022-11-14 | $688.10K 10-Q · filed 2021-11-15 | $1.18M derived: sum of 2 quarters · filed 2022-11-14 | $1.79M 10-Q · filed 2022-11-14 | $1.74M 10-Q · filed 2021-11-15 | $2.14M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $467.61K 10-Q · filed 2022-08-15 | $1.05M 10-Q · filed 2022-08-15 | $1.43M derived: sum of 3 quarters · filed 2022-08-15 | $1.96M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $582.57K 10-Q · filed 2022-05-16 | $965.57K derived: sum of 2 quarters · filed 2022-05-16 | $1.49M derived: sum of 3 quarters · filed 2022-05-16 | $1.65M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $383.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $905.23K derived: sum of 2 quarters · filed 2022-04-06 | $1.06M derived: sum of 3 quarters · filed 2022-04-06 | $1.72M 10-K · filed 2022-04-06 | ||||
| 2020-09-30 | $522.22K 10-Q · filed 2021-11-15 | $8.22K 10-Q · filed 2020-11-03 | $681.51K derived: sum of 2 quarters · filed 2021-11-15 | $1.34M 10-Q · filed 2021-11-15 | -$15.55K 10-Q · filed 2020-11-03 | $1.37M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $159.29K 10-Q · filed 2021-08-12 | -$10.77K 10-Q · filed 2020-08-11 | $814.60K 10-Q · filed 2021-08-12 | -$23.77K 10-Q · filed 2020-08-11 | $848.92K derived: sum of 3 quarters · filed 2021-08-12 | $856.59K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $655.31K 10-Q · filed 2021-05-18 | -$12.99K 10-Q · filed 2020-05-08 | $689.63K derived: sum of 2 quarters · filed 2021-05-18 | $697.30K derived: sum of 3 quarters · filed 2021-05-18 | $701.93K derived: sum of 4 quarters · filed 2021-05-18 | |||
| 2019-12-31 | $34.32K derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-03-30 | $42.00K derived: sum of 2 quarters · filed 2021-03-30 | $46.62K derived: sum of 3 quarters · filed 2021-03-30 | $55.89K 10-K · filed 2021-03-30 | ||||
| 2019-09-30 | $7.67K 10-Q/A · filed 2020-11-09 | $12.30K derived: sum of 2 quarters · filed 2020-11-09 | $21.57K 10-Q/A · filed 2020-11-09 | $14.84K derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $4.63K 10-Q · filed 2020-08-11 | $13.89K 10-Q · filed 2020-08-11 | $7.17K derived: sum of 3 quarters · filed 2020-08-11 | $29.54K derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $9.27K 10-Q · filed 2020-05-08 | $2.54K derived: sum of 2 quarters · filed 2020-05-08 | $24.91K derived: sum of 3 quarters · filed 2020-05-08 | $50.56K derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | -$6.72K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | $15.64K derived: sum of 2 quarters · filed 2020-03-31 | $41.30K derived: sum of 3 quarters · filed 2020-03-31 | $28.77K 10-K · filed 2020-03-31 | ||||
| 2018-09-30 | $22.37K 10-Q · filed 2019-11-14 | $48.02K derived: sum of 2 quarters · filed 2019-11-14 | $35.49K 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | $25.65K 10-Q · filed 2019-08-09 | $13.12K 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | -$12.53K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |